[How to deal with familial dyslipidemia in clinical practice?]
- PMID: 22471110
[How to deal with familial dyslipidemia in clinical practice?]
Abstract
Familial dyslipidemias are common in the population and correlated with increased risk of cardiovascular disease at young age. The early detection of individuals at high-risk may delay the vascular events and offer an increased quality of life and life expectancy. Screening is recommended in infancy in case of positive family history of premature cardiovascular disease. Lifestyle modifications and eviction of any additive cardiovascular risk are the first step before considering treatment. Statins may be introduced between age 10 to 50 depending on the severity of the familial history, the elevation of the lipid values and the presence of vascular dysfunction.
Similar articles
-
Lipoprotein(a) and family history of cardiovascular disease in children with familial dyslipidemias.J Pediatr. 2011 Aug;159(2):314-9. doi: 10.1016/j.jpeds.2011.01.038. Epub 2011 Mar 10. J Pediatr. 2011. PMID: 21392785
-
Identification and management of dyslipidemic children.Minerva Pediatr. 2009 Aug;61(4):391-8. Minerva Pediatr. 2009. PMID: 19752848 Review.
-
Management of inherited atherogenic dyslipidemias in children.Ther Apher Dial. 2013 Apr;17(2):150-61. doi: 10.1111/j.1744-9987.2012.01146.x. Epub 2012 Dec 16. Ther Apher Dial. 2013. PMID: 23551671 Review.
-
Pathogenesis and management of the dyslipidemia of the metabolic syndrome.Metab Syndr Relat Disord. 2009 Apr;7(2):83-8. doi: 10.1089/met.2008.0079. Metab Syndr Relat Disord. 2009. PMID: 19400742 Review.
-
[New european guidelines for dyslipidemia].Rev Med Suisse. 2012 Mar 7;8(331):525-6, 528-30. Rev Med Suisse. 2012. PMID: 22471115 French.
Cited by
-
Dyslipidemia in Infants: Challenges in Diagnosis and Management.Tunis Med. 2024 Dec 5;102(12):1084-1088. doi: 10.62438/tunismed.v102i12.4494. Tunis Med. 2024. PMID: 39748699 Free PMC article. English.